CNS activity of trastuzumab deruxtecan in HER2-expressing non-small-cell lung cancer. Lazaratos AM, Petrecca K, Guiot MC, Jerzak KJ, et al. Lancet Oncol 2024;25:e282.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lazaratos AM, Petrecca K, Guiot MC, Jerzak KJ, et al. CNS activity of trastuzumab deruxtecan in HER2-expressing non-small-cell lung cancer. Lancet Oncol 2024;25:e282.
PMID: 38936381